Healthcare & Life Sciences

Pharma Latch

series-c-plus
series-c-plus
Stage
1
Investors

About

Pharma Latch develops intradermal drug delivery devices based on microneedle technology to enable simple, reliable, and repeatable administration of vaccines, biologics, immunotherapies, and cell therapies.

Explore Pharma Latch's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.